These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

615 related items for PubMed ID: 11174469

  • 1. Vascular endothelial growth factor in peritoneal dialysis: a longitudinal follow-up.
    Zweers MM, Struijk DG, Smit W, Krediet RT.
    J Lab Clin Med; 2001 Feb; 137(2):125-32. PubMed ID: 11174469
    [Abstract] [Full Text] [Related]

  • 2. Growth factors VEGF and TGF-beta1 in peritoneal dialysis.
    Zweers MM, de Waart DR, Smit W, Struijk DG, Krediet RT.
    J Lab Clin Med; 1999 Aug; 134(2):124-32. PubMed ID: 10444025
    [Abstract] [Full Text] [Related]

  • 3. Vascular endothelial growth factor (VEGF) levels in peritoneal dialysis effluent.
    Selgas R, del Peso G, Bajo MA, Molina S, Cirugeda A, Sánchez-Tomero JA, Castro MJ, Castro MA, Vara F.
    J Nephrol; 2001 Aug; 14(4):270-4. PubMed ID: 11506249
    [Abstract] [Full Text] [Related]

  • 4. Serum level of vascular endothelial growth factor is influenced by erythropoietin treatment in peritoneal dialysis patients. (Grupo de Estudios Peritoneales de Madrid).
    del Peso G, Selgas R, Bajo MA, Fernández de Castro M, Aguilera A, Cirugeda A, Jiménez C.
    Adv Perit Dial; 2000 Aug; 16():85-9. PubMed ID: 11045267
    [Abstract] [Full Text] [Related]

  • 5. The effect of oxidative stress inhibition with trimetazidine on the peritoneal alterations induced by hypertonic peritoneal dialysis solution.
    Günal AI, Celiker H, Ustundag B, Akpolat N, Dogukan A, Akcicek F.
    J Nephrol; 2003 Aug; 16(2):225-30. PubMed ID: 12768069
    [Abstract] [Full Text] [Related]

  • 6. Differences in peritoneal equilibration test results in patients aged above or below 60 years.
    Grzegorzewska AE, Leander M, Mariak I.
    Adv Perit Dial; 2002 Aug; 18():33-9. PubMed ID: 12402583
    [Abstract] [Full Text] [Related]

  • 7. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor.
    Aroeira LS, Aguilera A, Selgas R, Ramírez-Huesca M, Pérez-Lozano ML, Cirugeda A, Bajo MA, del Peso G, Sánchez-Tomero JA, Jiménez-Heffernan JA, López-Cabrera M.
    Am J Kidney Dis; 2005 Nov; 46(5):938-48. PubMed ID: 16253736
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of effluent markers cancer antigen 125, vascular endothelial growth factor, and interleukin-6: relationship with peritoneal transport.
    Rodrigues A, Martins M, Santos MJ, Fonseca I, Oliveira JC, Cabrita A, Melo e Castro J, Krediet RT.
    Adv Perit Dial; 2004 Nov; 20():8-12. PubMed ID: 15384786
    [Abstract] [Full Text] [Related]

  • 9. Effect of amino acid based dialysate on peritoneal blood flow and permeability in stable CAPD patients: a potential role for nitric oxide?
    Douma CE, de Waart DR, Struijk DG, Krediet RT.
    Clin Nephrol; 1996 May; 45(5):295-302. PubMed ID: 8738660
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of peritoneal transport properties at onset of peritoneal dialysis and longitudinal follow-up.
    Clerbaux G, Francart J, Wallemacq P, Robert A, Goffin E.
    Nephrol Dial Transplant; 2006 Apr; 21(4):1032-9. PubMed ID: 16364990
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of peritoneal transport and membrane status in peritoneal dialysis: focus on incident fast transporters.
    Rodrigues AS, Martins M, Korevaar JC, Silva S, Oliveira JC, Cabrita A, Castro e Melo J, Krediet RT.
    Am J Nephrol; 2007 Apr; 27(1):84-91. PubMed ID: 17284895
    [Abstract] [Full Text] [Related]

  • 12. Peritonitis, peritoneal inflammation and membrane permeability: a longitudinal study of dialysate and serum MCP-1 in stable patients on peritoneal dialysis.
    Malik AR, Little MA, Henriksson M, Tam FW, Brown EA.
    J Nephrol; 2007 Apr; 20(3):340-9. PubMed ID: 17557268
    [Abstract] [Full Text] [Related]

  • 13. Intra-peritoneal interleukin-6 system is a potent determinant of the baseline peritoneal solute transport in incident peritoneal dialysis patients.
    Oh KH, Jung JY, Yoon MO, Song A, Lee H, Ro H, Hwang YH, Kim DK, Margetts P, Ahn C.
    Nephrol Dial Transplant; 2010 May; 25(5):1639-46. PubMed ID: 20061317
    [Abstract] [Full Text] [Related]

  • 14. Intraperitoneal vascular endothelial growth factor C level is related to peritoneal dialysis ultrafiltration.
    Yang WS, Tsai TJ, Shih CL, Huang JW, Chuang HF, Chen MH, Fang CC.
    Blood Purif; 2009 May; 28(1):69-74. PubMed ID: 19439926
    [Abstract] [Full Text] [Related]

  • 15. Impact of systemic and local peritoneal inflammation on peritoneal solute transport rate in new peritoneal dialysis patients: a 1-year prospective study.
    Cho JH, Hur IK, Kim CD, Park SH, Ryu HM, Yook JM, Choi JY, Choi HJ, Choi HJ, Park JW, Do JY, Kim YL.
    Nephrol Dial Transplant; 2010 Jun; 25(6):1964-73. PubMed ID: 20100731
    [Abstract] [Full Text] [Related]

  • 16. The cellular contribution to effluent potassium and its relation to free water transport during peritoneal dialysis.
    Coester AM, Struijk DG, Smit W, de Waart DR, Krediet RT.
    Nephrol Dial Transplant; 2007 Dec; 22(12):3593-600. PubMed ID: 17664179
    [Abstract] [Full Text] [Related]

  • 17. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
    Theodoridis M, Passadakis P, Kriki P, Gioka T, Panagoutsos S, Mourvati E, Thodis E, Kantartzi K, Vargemezis V.
    Ren Fail; 2008 Dec; 30(2):161-7. PubMed ID: 18300115
    [Abstract] [Full Text] [Related]

  • 18. Neutral-pH peritoneal dialysis solution improves peritoneal function and decreases matrix metalloproteinase-2 (MMP-2) in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
    Nishina M, Endoh M, Suzuki D, Tanabe R, Endoh H, Hirahara I, Sakai H.
    Clin Exp Nephrol; 2004 Dec; 8(4):339-43. PubMed ID: 15619033
    [Abstract] [Full Text] [Related]

  • 19. Peritoneal fast transport in incident peritoneal dialysis patients is not consistently associated with systemic inflammation.
    Rodrigues AS, Almeida M, Fonseca I, Martins M, Carvalho MJ, Silva F, Correia C, Santos MJ, Cabrita A.
    Nephrol Dial Transplant; 2006 Mar; 21(3):763-9. PubMed ID: 16332703
    [Abstract] [Full Text] [Related]

  • 20. The relationship between peritoneal transport characteristics and messenger RNA expression of aquaporin in the peritoneal dialysis effluent of CAPD patients.
    Szeto CC, Lai KB, Chow KM, Szeto CY, Li PK.
    J Nephrol; 2005 Mar; 18(2):197-203. PubMed ID: 15931648
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.